Literature DB >> 33777439

Re: The Bacillus Calmette-Guerin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?

Mahmood D Al-Mendalawi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33777439      PMCID： PMC7968909          DOI： 10.18295/squmj.2021.21.01.023

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN： 2075-051X


× No keyword cloud information.
  10 in total

Review 1.  False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?

Authors:  M Farhat; C Greenaway; M Pai; D Menzies
Journal:  Int J Tuberc Lung Dis       Date:  2006-11       Impact factor: 2.373

2.  The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.

Authors:  James D Mancuso; Rupal M Mody; Cara H Olsen; Lee H Harrison; Mathuram Santosham; Naomi E Aronson
Journal:  Chest       Date:  2017-01-10       Impact factor: 9.410

3.  Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.

Authors:  L C Rodrigues; V K Diwan; J G Wheeler
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

4.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

5.  Does effect of BCG vaccine decrease with time since vaccination and increase tuberculin skin test reaction?

Authors:  R Subramani; Manjula Datta; S Swaminathan
Journal:  Indian J Tuberc       Date:  2016-01-23

6.  The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.

Authors:  Zaida Araujo; Jacobus Henri de Waard; Carlos Fernández de Larrea; Rafael Borges; Jacinto Convit
Journal:  Vaccine       Date:  2008-08-22       Impact factor: 3.641

7.  [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].

Authors:  Ciğdem Yildirim; Ali Ihsan Küçük; Gözde Ongüt; Dilara Oğünç; Dilek Colak; Gönül Mutlu
Journal:  Mikrobiyol Bul       Date:  2009-01       Impact factor: 0.622

8.  Bacillus Calmette-Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study.

Authors:  Avtar Kishan Jaisinghani; Vivek Kumar Dey; M S Suresh; Animesh Saxena
Journal:  Indian J Dermatol       Date:  2019 Mar-Apr       Impact factor: 1.494

9.  Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.

Authors:  Kathryn T Whelan; Ansar A Pathan; Clare R Sander; Helen A Fletcher; Ian Poulton; Nicola C Alder; Adrian V S Hill; Helen McShane
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

10.  The Bacillus Calmette-Guérin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?

Authors:  Asaad Q Al-Yassen; Shukrya K Al-Maliki; Jasim N Al-Asadi
Journal:  Sultan Qaboos Univ Med J       Date:  2020-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.